Structures of rat and human islet amyloid polypeptide IAPP1-19 in micelles by NMR spectroscopy

Biochemistry

Volumn 47, Issue 48, 2008, Pages 12689-12697

  Nanga, Ravi Prakash Reddy ^a   Brender, Jeffrey R ^a   Xu, Jiadi ^a   Veglia, Gianluigi ^b   Ramamoorthy, Ayyalusamy ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CELL MEMBRANES; COLLOIDS; MEMBRANES; MICELLES; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDES; PROTEINS; QUENCHING; TOPOLOGY; TOXIC MATERIALS;

AMYLOIDOGENIC PEPTIDES; ATOMIC LEVELS; BOUND STATES; CELLULAR MEMBRANES; DEPROTONATING; HELICAL CONFORMATIONS; HELICAL STRUCTURES; HUMAN ISLETS; IN VITRO; IN-VIVO; LOW TOXICITIES; MEMBRANE DISRUPTIONS; MEMBRANE ORIENTATIONS; NMR SPECTROSCOPIES; STRUCTURAL DETAILS; TRANSMEMBRANE; TYPE 2 DIABETES;

AMINES;

AMYLIN;

ALPHA HELIX; ARTICLE; HUMAN; MEMBRANE DAMAGE; MICELLE; NONHUMAN; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SPECIES DIFFERENCE;

AMYLOID; ANIMALS; DETERGENTS; HUMANS; HYDROPHOBICITY; MAGNETIC RESONANCE SPECTROSCOPY; MICELLES; MODELS, MOLECULAR; PHOSPHATIDYLCHOLINES; PHOSPHORYLCHOLINE; PROTEIN DENATURATION; PROTEIN STRUCTURE, SECONDARY; RATS;

RATTUS;

EID: 57049174009     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi8014357     Document Type: Article

References (58)

1. Bailey, C. J. (1999) New pharmacological approaches to glycemic control. Diabetes Rev. 7, 94-113.
2. Cooper, G. J. S. (1994) Amylin compared with calcitonin-gene-related peptide-Structure, biology, and relevance to metabolic disease. Endocr. Rev. 15, 163-201.
3. Reda, T. K., Geliebter, A., and Pi-Sunyer, F. X. (2002) Amylin, food intake, and obesity. Obes. Res. 10, 1087-1091.
4. Makin, O. S., and Serpell, L. C. (2005) Structures for amyloid fibrils. FEBS J. 272, 5950-5961.
5. Clark, A., and Nilsson, M. R. (2004) Islet amyloid: a complication of islet dysfunction or an aetiological factor in type 2 diabetes? Diabetologia 47, 157-169.
6. Quist, A., Doudevski, L., Lin, H., Azimova, R., Ng, D., Frangione, B., Kagan, B., Ghiso, J., and Lal, R. (2005) Amyloid ion channels: A common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. U.S.A. 102, 10427-10432.
7. Demuro, A., Mina, E., Kayed, R., Milton, S. C., Parker, I., and Glabe, C. G. (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280, 17294-17300.
8. Kayed, R., Sokolov, Y., Edmonds, B., McIntire, T. M., Milton, S. C., Hall, J. E., and Glabe, C. G. (2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279, 46363-46366.
9. Ferreira, S. T., Vieira, M. N. N., and De Felice, F. G. (2007) Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases. IUBMB Life 59, 332-345.
10. Engel, M. F., Khemtemourian, L., Kleijer, C. C., Meeldijk, H. J., Jacobs, J., Verkleij, A. J., de Kruijff, B., Killian, J. A., and Hoppener, J. W. (2008) Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane. Proc. Natl. Acad. Sci. U.S.A. 105, 6033-6038.
11. Sparr, E., Engel, M. F. M., Sakharov, D. V., Sprong, M., Jacobs, J., de Kruijff, B., Hoppener, J. W. M., and Killian, J. A. (2004) Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers. FEBS Lett. 577, 117-120.
12. Brender, J. R., Lee, E. L., Cavitt, M. A., Gafni, A., Steel, D. G., and Ramamoorthy, A. (2008) Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP. The type-2-biabetes-related peptide. J. Am. Chem. Soc. 130, 6424-6429.
13. Engel, M. F. M., Yigittop, H., Elgersma, R. C., Rijkers, D. T. S., Liskamp, R. M. J., de Kruijff, B., Hoppener, J. W. M., and Killian, J. A. (2006) Islet amyloid polypeptide inserts into phospholipid monolayers as monomer. J. Mol. Biol. 356, 783-789.
14. Lopes, D. H. J., Meister, A., Gohlke, A., Hauser, A., Blume, A., and Winter, R. (2007) Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy. Biophys. J. 93, 3132-3141.
15. Westermark, P., Engstrom, U., Johnson, K. H., Westermark, G. T., and Betsholtz, C. (1990) Islet amyloid polypeptide - Pinpointing amino-acid-residues linked to amyloid fibril formation. Proc. Natl. Acad. Sci. U.S.A. 87, 5036-5040.
16. Jaikaran, E., Higham, C. E., Serpell, L. C., Zurdo, J., Gross, M., Clark, A., and Fraser, P. E. (2001) Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. J. Mol. Biol. 308, 515-525.
17. Mazor, Y., Gilead, S., Benhar, I., and Gazit, E. (2002) Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide. J. Mol. Biol. 322, 1013-1024.
18. Knight, J. D., Hebda, J. A., and Miranker, A. D. (2006) Conserved and cooperative assembly of membrane-bound α-helical states of islet amyloid polypeptide. Biochemistry 45, 9496-9508.
19. Brender, J. R., Hartman, K., Reid, K. R., Kennedy, R. T., and Ramamoorthy, A. (2008) A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity. Biochemistry 47, 12680-12688.
20. Radovan, D., Smirnovas, V., and Winter, R. (2008) Effect of pressure on islet amyloid polypeptide aggregation: Revealing the polymorphic nature of the fibrillation process. Biochemistry 47, 6352-6360.
21. Apostolidou, M., Jayasinghe, S. A., and Langen, R. (2008) Structure of α-helical membrane-bound hIAPP and its implications for membrane-mediated misfolding. J. Biol. Chem. 283, 17205-17210.
22. Crescenzi, O., Tomaselli, S., Guerrini, R., Salvadori, S., D'Ursi, A. M., Temussi, P. A., and Picone, D. (2002) Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment - Similarity with a virus fusion domain. Eur. J. Biochem. 269, 5642-5648.
23. Buck, M. (1998) Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides and proteins. Q. Rev. Biophys. 31, 297-355.
24. Sanders, C. R., and Sonnichsen, F. (2006) Solution NMR of membrane proteins: practice and challenges. Magn. Reson. Chem. 44, S24-S40.
25. Zamoon, J., Mascioni, A., Thomas, D. D., and Veglia, G. (2003) NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles. Biophys. J. 85, 2589-2598.
26. 2+-ATPase complex. J. Mol. Biol. 358, 1041-1050.
27. Zamoon, J., Nitu, F., Karim, C., Thomas, D. D., and Veglia, G. (2005) Mapping the interaction surface of a membrane protein: Unveiling the conformational switch of phospholamban in calcium pump regulation. Proc. Natl. Acad. Sci. U.S.A. 102, 4747-4752.
28. Vinogradova, O., Sonnichsen, F., and Sanders, C. R. (1998) On choosing a detergent for solution NMR studies of membrane proteins. J. Biomol. NMR 11, 381-386.
29. Porcelli, F., Buck-Koehntop, B. A., Thennarasu, S., Ramamoorthy, A., and Veglia, G. (2006) Structures of the dimeric and monomelic variants of magainin antimicrobial peptides (MSI-78 and MSI-594) in micelles and bilayers, determined by NMR spectroscopy. Biochemistry 45, 5793-5799.
30. Porcelli, F., Verardi, R., Shi, L., Henzler-Wildman, K. A., Ramamoorthy, A., and Veglia, G. (2008) NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles. Biochemistry 47, 5565-5572.
31. Bax, A., and Davis, D. G. (1985) MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65, 355-360.
32. Kumar, A., Ernst, R. R., and Wuthrich, K. (1980) A two-dimensional nuclear overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem. Biophys. Res. Commun. 95, 1-6.
33. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRpipe - a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293.
34. Kneller, D. G., and Kuntz, I. D. (1993) UCSF Sparky - an NMR display, annotation and assignment tool. J. Cell. Biochem. 254-254.
35. Wuthrich, K. (1986) NMR of Proteins and Nucleic Acids, John Wiley and Sons, New York.
36. Nilges, M., Gronenborn, A. M., Brunger, A. T., and Clore, G. M. (1988) Determination of 3-dimensional structures of proteins by simulated annealing with interproton distance restraints - application to crambin, potato carboxypeptidase inhibitor and barley serine proteinase inhibitor-2. Protein Eng. 2, 27-38.
37. Schwieters, C. D., Kuszewski, J. J., Tjandra, N., and Clore, G. M. (2003) The Xplor-NIH NMR molecular structure determination package. J. Magn. Reson. 160, 65-73.
38. Cornilescu, G., Delaglio, F., and Bax, A. (1999) Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13, 289-302.
39. Laskowski, R. A., Rullmann, J. A. C., MacArthur, M. W., Kaptein, R., and Thornton, J. M. (1996) AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8, 477-486.
40. Koradi, R., Billeter, M., and Wuthrich, K. (1996) MOLMOL: A program for display and analysis of macromolecular structures. J. Mol. Graphics 14, 51-55.
41. Lashuel, H. A., and Lansbury, P. T. (2006) Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Q. Rev. Biophys. 39, 167-201.
42. Haataja, L., Gurlo, T., Huang, C. J., and Butler, P. C. (2008) Islet Amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr. Rev. 29, 302-316.
43. Jayasinghe, S. A., and Langen, R. (2005) Lipid membranes modulate the structure of islet amyloid polypeptide. Biochemistry 44, 12113-12119.
44. (a) Bokvist, M., Lindstrom, F., Watts, A., and Grobner, G. (2004) Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: Aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. J. Mol. Biol. 335, 1039-1049.
45. (b) Ilangovan, U., and Ramamoorthy, A. (1998) Conformational studies of human islet amyloid peptide using molecular dynamics and simulated annealing methods. Biopolymers 45, 9.
46. Davidson, W. S., Jonas, A., Clayton, D. F., and George, J. M. (1998) Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 9443-9449.
47. Mascioni, A., Porcelli, F., Ilangovan, U., Ramamoorthy, A., and Venglia, G. (2003) Conformational preferences of the amylin nucleation site in SDS micelles: An NMR study. Biopolymers 69, 29-41.
48. Tenidis, K., Waldner, M., Bernhagen, J., Fischle, W., Bergmann, M., Weber, M., Merkle, M. L., Voelter, W., Brunner, H., and Kapurniotu, A. (2000) Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J. Mol. Biol. 295, 1055-1071.
49. Williamson, J. A., and Miranker, A. D. (2007) Direct detection of transient α-helical states in islet amyloid polypeptide. Protein Sci. 16, 110-117.
50. Yonemoto, I. T., Kroon, G. J., Dyson, H. J., Balch, W. E., and Kelly, J. W. (2008) Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical state. Biochemistry 47, 9900-9910.
51. Jarvet, J., Danielsson, J., Damberg, P., Oleszczuk, M., and Graeslund, A. (2007) Positioning of the Alzheimer Abeta(1-40) peptide in SDS micelles using NMR and paramagnetic probes. J. Biomol. NMR 39, 63-72.
52. Daily, A. E., Greathouse, D. V., van der Wel, P. C. A., and Koeppe, R. E. (2008) Helical distortion in tryptophan- and lysine-anchored membrane-spanning alpha-helices as a function of hydrophobic mismatch: A solid-state deuterium NMR investigation using the geometric analysis of labeled alanines method. Biophys. J. 94, 480-491.
53. Balali-Mood, K., Ashley, R. H., Hauss, T., and Bradshaw, J. P. (2005) Neutron diffraction reveals sequence-specific membrane insertion of pre-fibrillar islet amyloid polypeptide and inhibition by rifampicin. FEBS Lett. 579, 1143-1148.
54. Motta, A., Andreotti, G., Amodeo, P., Strazzullo, G., and Morelli, M. A. C. (1998) Solution structure of human calcitonin in membrane-mimetic environment: The role of the amphipathic helix. Proteins 32, 314-323.
55. Roberts, E., Eargle, J., Wright, D., and Luthey-Schulten, Z. (2006) MultiSeq: Unifying sequence and structure data for evolutionary analysis. BMC Bioinf. 7, 382-392.
56. Humphrey, W., Dalke, A., and Schulten, K. (1996) VMD: Visual molecular dynamics. J. Mol. Graphics 14, 33-38.
57. Henzler-Wildman, K. A., Martinez, G. V., Brown, M. F., and Ramamoorthy, A. (2004) Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37. Biochemistry 43, 8459-8469.
58. Ramamoorthy, A., Thennarasu, S., Tan, A., Lee, D. K., Clayberger, C., and Krensky, A. M. (2006) Cell selectivity correlates with membrane interactions: a case study on the antimicrobial peptide G15 derived from granulysin. Biochim. Biophys. Acta 1758, 154-163.